Juno Therapeutics, Inc. Company Profile
✉ Email this page to a colleague
Biologic Drugs for Juno Therapeutics, Inc.
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Juno Therapeutics, Inc. A Bristol Myer-squibb Company | BREYANZI | lisocabtagene maraleucel | Injection | 125714 | 10,736,918 | 2037-11-17 | DrugPatentWatch analysis and company disclosures |
| Juno Therapeutics, Inc. A Bristol Myer-squibb Company | BREYANZI | lisocabtagene maraleucel | Injection | 125714 | 10,780,118 | 2033-08-20 | DrugPatentWatch analysis and company disclosures |
| Juno Therapeutics, Inc. A Bristol Myer-squibb Company | BREYANZI | lisocabtagene maraleucel | Injection | 125714 | 7,446,190 | 2023-05-28 | DrugPatentWatch analysis and company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.
